The efficacy and safety of sequential use of anlotinib and 131I for locally advanced or metastatic differentiated thyroid cancer: A single-arm phase II clinical trial

被引：0
|
作者：
Song, Hongjun
Qiu, Xian
He, Ziyan
Chen, Libo
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 6, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Peoples Hosp 6, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18102
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The Efficacy and Safety of Anlotinib in Neoadjuvant Treatment of Locally Advanced Thyroid Cancer: A Single-Arm Phase II Clinical Trial
    Huang, Nai-si
    Wei, Wen-jun
    Xiang, Jun
    Chen, Jia-ying
    Guan, Qing
    Lu, Zhong-wu
    Ma, Ben
    Sun, Guo-hua
    Wang, Yu-long
    Ji, Qing-hai
    Wang, Yu
    THYROID, 2021, 31 (12) : 1808 - 1813
  • [2] The efficacy and safety of anlotinib in neoadjuvant treatment in locally advanced thyroid cancer: A single-arm phase II clinical trial.
    Huang, Naisi
    Sun, Guohua
    Wang, Yulong
    Chen, Jiaying
    Guan, Qing
    Lu, Zhongwu
    Xiang, Jun
    Wei, Wenjun
    Ma, Ben
    Ji, Qinghai
    Wang, Yu
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] A prospective, single-arm, open-label, phase II clinical trial on efficacy and safety of cadonilimab plus anlotinib for recurrent, metastatic or persistent cervical cancer
    Yang, Chunxu
    Sun, Shaoxing
    Xiang, Qingming
    Chen, Min
    Mei, Zijie
    Wu, Qiuji
    Qiu, Hui
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S290 - S290
  • [4] Efficacy and safety of anlotinib in patients with advanced malignancy: a single-center, single-arm, phase 2 trial
    Yihebali Chi
    Guangqian Ji
    Jing Zhang
    Haijian Tang
    Yang Yang
    Wei Liu
    Nan Wang
    Chunhui Gao
    Yongkun Sun
    Jinwan Wang
    International Journal of Clinical Oncology, 2021, 26 : 1611 - 1618
  • [5] Efficacy and safety of anlotinib in patients with advanced malignancy: a single-center, single-arm, phase 2 trial
    Chi, Yihebali
    Ji, Guangqian
    Zhang, Jing
    Tang, Haijian
    Yang, Yang
    Liu, Wei
    Wang, Nan
    Gao, Chunhui
    Sun, Yongkun
    Wang, Jinwan
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (09) : 1611 - 1618
  • [6] A single-arm, phase II, multicenter trial of sunitinib maleate (SU) in locally advanced or metastatic
    Leibowitz-Amit, Raya
    Joshua, Anthony Michael
    Ezzat, Shereen
    Bourdeau, Isabelle
    Olney, Harold
    Oosting, Sjoukje
    Ruether, Joseph D.
    Chin, Soo
    Palmieri, Cristina
    Seah, Jo-An
    Assa, Sylvia L.
    Krzyzanowska, Monika
    Knox, Jennifer J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [7] A single-arm, phase II clinical trial of neoadjuvant pegylated liposomal doxorubicin plus anlotinib in locally advanced soft tissue sarcoma
    Chen, Y.
    Sun, W.
    Wang, S.
    Xu, Y.
    Hu, T.
    Zheng, B.
    Sun, Z.
    Wang, C.
    Yan, W.
    ANNALS OF ONCOLOGY, 2023, 34 : S1045 - S1045
  • [8] A single-arm phase II clinical trial of anlotinib combined with chemotherapy for the treatment of metastatic triple-negative breast cancer
    Huang, Jia-Yi
    Xie, Xiao-Feng
    Chen, Xue-Lian
    Zhang, Qiu-Yi
    Chen, Li-Ping
    Bai, Xue
    Lan, Xiao-Feng
    Song, Lin
    Guo, Jin-Feng
    Du, Cai-Wen
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [9] Anlotinib plus sintilimab in patients with recurrent advanced cervical cancer: A prospective, multicenter, single-arm, phase II clinical trial
    Xu, Q.
    Chen, C.
    Huang, Z.
    Lin, Y.
    Liu, J.
    Li, L.
    Li, Z.
    Pan, J.
    Chen, Y.
    ANNALS OF ONCOLOGY, 2021, 32 : S752 - S753
  • [10] Anlotinib in locally advanced or metastatic radioiodinerefractory differentiated thyroid carcinoma: A randomized, double-blind, multicenter phase II trial
    Chi, Y.
    Gao, M.
    Zhang, Y.
    Shi, F.
    Cheng, Y.
    Guo, Z.
    Ge, M.
    Qin, J.
    Zhang, J.
    Li, Z.
    Zhou, X.
    Huang, R.
    Chen, X.
    Liu, H.
    Cheng, R.
    Xu, Z.
    Zheng, X.
    Li, D.
    Tang, P.
    ANNALS OF ONCOLOGY, 2020, 31 : S1347 - S1347
12345